Active Ingredient History
Rituximab, sold under the brand name Rituxan among others, is a monoclonal antibody medication used to treat certain autoimmune diseases and types of cancer. It is used for non-Hodgkin lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura, pemphigus vulgaris, myasthenia gravis and Epstein–Barr virus-positive mucocutaneous ulcers. It is given by slow intravenous infusion. Biosimilars of Rituxan include Blitzima, Riabni, Ritemvia, Rituenza, Rixathon, Ruxience, and Truxima. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Combination drugs
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Acne Vulgaris (Early Phase 1)
Acquired Immunodeficiency Syndrome (Phase 2/Phase 3)
Affective Disorders, Psychotic (Phase 2)
Aged (Phase 2)
Allergy and Immunology (Phase 4)
Allogeneic Cells (Phase 2)
Ambulatory Care (Phase 2)
Anemia (Phase 3)
Anemia, Aplastic (Phase 2)
Anemia, Diamond-Blackfan (Phase 2)
Anemia, Hemolytic, Autoimmune (Phase 4)
Anemia, Sickle Cell (Phase 2)
Antigens, CD19 (Phase 1/Phase 2)
Antigens, CD20 (Phase 2)
Antiphospholipid Syndrome (Phase 2)
Arthritis, Psoriatic (Phase 1)
Ataxia (Phase 1/Phase 2)
Autoantibodies (Phase 4)
Autoimmune Diseases (Phase 4)
Autoimmune Pancreatitis (Phase 1/Phase 2)
Behcet Syndrome (Phase 2)
beta-Thalassemia (Phase 2)
Bone Marrow Cells (Phase 1)
Bone Marrow Transplantation (Phase 2)
Brain Diseases (Phase 1)
Brain Neoplasms (Phase 2)
Breast Neoplasms (Phase 2)
Burkitt Lymphoma (Phase 4)
Candidiasis (Phase 1)
Carcinoma, Non-Small-Cell Lung (Phase 1)
Carcinoma, Renal Cell (Phase 1)
Castleman Disease (Phase 2)
Chemotherapy, Cancer, Regional Perfusion (Phase 2)
Chimera (Phase 1/Phase 2)
Cholangitis (Phase 1)
Choroidal Neovascularization (Phase 1/Phase 2)
Chromosome Aberrations (Phase 2)
Chronic Kidney Disease-Mineral and Bone Disorder (Phase 1/Phase 2)
Churg-Strauss Syndrome (Phase 2)
Cisplatin (Phase 2)
Clonal Hematopoiesis (Phase 2)
Cogan Syndrome (Phase 2)
Cognition Disorders (Phase 2)
Colitis, Ulcerative (Phase 2/Phase 3)
Collagen Diseases (Phase 2/Phase 3)
Colonic Neoplasms (Phase 2)
Composite Lymphoma (Phase 1/Phase 2)
Connective Tissue Diseases (Phase 4)
Cryoglobulinemia (Phase 2)
Cyclin D1 (Phase 2)
Cyclin D2 (Phase 2)
Cyclin D3 (Phase 2)
Cyclophosphamide (Phase 2)
Cystinosis (Phase 1/Phase 2)
Demyelinating Autoimmune Diseases, CNS (Phase 3)
Demyelinating Diseases (Phase 3)
Dermatology (Phase 4)
Dermatomyositis (Phase 2)
Dexamethasone (Phase 2)
Diabetes Mellitus, Type 1 (Phase 4)
Diabetic Nephropathies (Phase 2)
Drug Combinations (Phase 4)
Drug Resistant Epilepsy (Phase 4)
Drugs, Investigational (Phase 3)
Drug Therapy (Phase 2)
Encephalitis (Phase 1)
Endoscopy (Phase 2)
Eosinophilic Granuloma (Phase 3)
Epstein-Barr Virus Infections (Phase 4)
Eye Diseases, Hereditary (Phase 1)
Fanconi Anemia (Phase 2)
Fatigue (Phase 2)
Fatigue Syndrome, Chronic (Phase 3)
Fetal Hemoglobin (Phase 2)
Fever (Phase 2)
Genetic Diseases, Inborn (Phase 1/Phase 2)
Geriatrics (Phase 3)
Giant Cell Arteritis (Phase 2)
Glomerulonephritis (Phase 2)
Glomerulonephritis, IGA (Phase 4)
Glomerulonephritis, Membranous (Phase 4)
Glomerulosclerosis, Focal Segmental (Phase 3)
Glycogen Storage Disease Type II (Phase 4)
Gout (Phase 1)
Graft Rejection (Phase 4)
Graft Survival (Phase 2)
Graft vs Host Disease (Phase 2)
Granuloma (Phase 4)
Graves Disease (Phase 1/Phase 2)
Graves Ophthalmopathy (Phase 4)
Growth and Development (Phase 2)
Heart Diseases (Phase 2)
Heart Failure, Systolic (Phase 2)
Heart Transplantation (Phase 2)
Hematologic Diseases (Phase 2)
Hematologic Neoplasms (Phase 2)
Hematopoietic Stem Cell Transplantation (Phase 2)
Hemoglobinuria, Paroxysmal (Phase 2)
Hemolytic-Uremic Syndrome (Phase 2)
Hemophilia A (Phase 4)
Hepatitis C (Phase 2)
Herpesvirus 8, Human (Phase 2)
Histiocytosis, Langerhans-Cell (Phase 2)
Histone Deacetylase Inhibitors (Phase 2)
HIV (Phase 2)
HIV Infections (Phase 4)
Hodgkin Disease (Phase 3)
Hyperplasia (Phase 2)
Hypertension, Pulmonary (Phase 2)
Hypertension, Renal (Phase 2)
Hyperthyroidism (Phase 1/Phase 2)
Hypoadrenocorticism, Familial (Phase 4)
Hypophosphatasia (Phase 4)
Idiopathic Pulmonary Fibrosis (Phase 2)
IgA Vasculitis (Phase 3)
Immune System Diseases (Phase 2)
Immunoglobulin G4-Related Disease (Phase 1)
Immunoglobulin M (Phase 2)
Immunoproliferative Disorders (Phase 2)
Immunosuppression Therapy (Phase 4)
Infections (Phase 2)
Infectious Mononucleosis (Phase 2)
Inflammation (Phase 2)
Informed Consent (Phase 2)
Intestinal Neoplasms (Phase 1/Phase 2)
Intraocular Lymphoma (Phase 2)
Keratoconjunctivitis Sicca (Phase 2)
Kidney Diseases (Phase 4)
Kidney Failure, Chronic (Phase 3)
Kidney Glomerulus (Phase 2)
Kidney Transplantation (Phase 4)
Learning (Phase 1)
Leukemia (Phase 3)
Leukemia, B-Cell (Phase 2)
Leukemia, Biphenotypic, Acute (Phase 2)
Leukemia, Hairy Cell (Phase 2)
Leukemia, Large Granular Lymphocytic (Phase 2)
Leukemia, Lymphoid (Phase 3)
Leukemia-Lymphoma, Adult T-Cell (Phase 2)
Leukemia, Myeloid, Acute (Phase 3)
Leukemia, Myeloid, Chronic-Phase (Phase 2)
Leukemia, Myelomonocytic, Chronic (Phase 2)
Leukemia, Myelomonocytic, Juvenile (Phase 2)
Leukemia, Prolymphocytic (Phase 2)
Livedoid Vasculopathy (Phase 2)
Liver Cirrhosis, Biliary (Phase 2)
Living Donors (Phase 2)
Lung Diseases (Phase 3)
Lung Diseases, Interstitial (Phase 3)
Lung Neoplasms (Phase 2)
Lung Transplantation (Phase 2)
Lupus Erythematosus, Systemic (Phase 4)
Lupus Nephritis (Phase 4)
Lymphadenopathy (Phase 2)
Lymphatic Diseases (Phase 2)
Lymphocytosis (Phase 2)
Lymphohistiocytosis, Hemophagocytic (Phase 3)
Lymphoma (Phase 4)
Lymphoma, AIDS-Related (Phase 2)
Lymphoma, B-Cell (Phase 4)
Lymphoma, B-Cell, Marginal Zone (Phase 3)
Lymphoma, Extranodal NK-T-Cell (Phase 2)
Lymphoma, Follicular (Phase 4)
Lymphoma, Large B-Cell, Diffuse (Phase 4)
Lymphoma, Large-Cell, Anaplastic (Phase 4)
Lymphoma, Large-Cell, Immunoblastic (Phase 3)
Lymphoma, Mantle-Cell (Phase 4)
Lymphoma, Non-Hodgkin (Phase 4)
Lymphoma, Primary Effusion (Phase 2)
Lymphoma, T-Cell (Phase 2/Phase 3)
Lymphoma, T-Cell, Peripheral (Phase 2)
Lymphomatoid Granulomatosis (Phase 2)
Lymphoproliferative Disorders (Phase 4)
Macular Degeneration (Phase 1/Phase 2)
Medial Collateral Ligament, Knee (Phase 2)
Mediastinal Neoplasms (Phase 4)
Melanoma (Phase 2)
Membranes (Phase 3)
Mental Disorders (Phase 3)
Mental Health (Phase 2)
Methotrexate (Phase 4)
Mixed Connective Tissue Disease (Phase 2/Phase 3)
Mucopolysaccharidoses (Phase 4)
Mucopolysaccharidosis II (Phase 4)
Mucositis (Phase 3)
Multiple Myeloma (Phase 2)
Multiple Sclerosis (Phase 3)
Multiple Sclerosis, Chronic Progressive (Phase 3)
Multiple Sclerosis, Relapsing-Remitting (Phase 3)
Multiple System Atrophy (Phase 2)
Muscular Diseases (Phase 1)
Mutation (Phase 2)
Myasthenia Gravis (Phase 3)
Mycosis Fungoides (Phase 1)
Myelodysplastic Syndromes (Phase 3)
Myeloid Cells (Phase 1)
Myeloproliferative Disorders (Phase 2)
Myocardial Infarction (Phase 1/Phase 2)
Myocardial Ischemia (Phase 1/Phase 2)
Myoclonus (Phase 1/Phase 2)
Myositis (Phase 2/Phase 3)
Neoplasm Metastasis (Phase 1/Phase 2)
Neoplasm, Residual (Phase 2)
Neoplasms ()
Neoplasms by Histologic Type (Phase 2)
Neoplasms, Germ Cell and Embryonal (Phase 2)
Nephritis (Phase 1/Phase 2)
Nephrosis, Lipoid (Phase 3)
Nephrotic Syndrome (Phase 4)
Nervous System Diseases (Phase 3)
Neuroblastoma (Phase 3)
Neurofibromatosis 1 (Phase 2)
Neuromyelitis Optica (Phase 4)
N-Myc Proto-Oncogene Protein (Phase 1/Phase 2)
Obsessive Behavior (Phase 2)
Obsessive-Compulsive Disorder (Phase 2)
Ocular Motility Disorders (Phase 1/Phase 2)
Opsoclonus-Myoclonus Syndrome (Phase 3)
Orbital Diseases (Phase 1/Phase 2)
Organ Transplantation (Phase 2)
Ovarian Diseases (Phase 2)
Pancreatic Neoplasms (Phase 2)
Paraparesis, Tropical Spastic (Phase 2)
Pediatrics (Phase 1)
Pemphigoid, Benign Mucous Membrane (Phase 1/Phase 2)
Pemphigoid, Bullous (Phase 3)
Pemphigus (Phase 4)
Peripheral Nervous System Diseases (Phase 2)
Pharmacology (Phase 2/Phase 3)
Plasmablastic Lymphoma (Phase 2)
Plasmacytoma (Phase 2)
Polyarteritis Nodosa (Phase 2)
Polychondritis, Relapsing (Phase 2)
Polymorphism, Genetic (Phase 2)
Polymyalgia Rheumatica (Phase 3)
Polymyositis (Phase 2)
Polyneuropathies (Phase 3)
Polyradiculoneuropathy (Phase 2)
Precancerous Conditions (Phase 2)
Prognosis (Phase 2)
Prostatic Neoplasms (Early Phase 1)
Proteinuria (Phase 3)
Psychotic Disorders (Phase 2)
Pulmonary Alveolar Proteinosis (Phase 2)
Pulmonary Arterial Hypertension (Phase 4)
Pulmonary Disease, Chronic Obstructive (Phase 1/Phase 2)
Purpura (Phase 3)
Purpura, Thrombocytopenic, Idiopathic (Phase 4)
Purpura, Thrombotic Thrombocytopenic (Phase 3)
Radiotherapy (Phase 2)
Recurrence (Phase 2)
Red-Cell Aplasia, Pure (Phase 2)
Remission Induction (Phase 4)
Renal Insufficiency (Phase 4)
Renal Insufficiency, Chronic (Phase 2)
Retinal Diseases (Phase 3)
Retroperitoneal Fibrosis (Phase 1/Phase 2)
Rheumatology (Early Phase 1)
Risk Factors (Phase 2)
Rituximab (Phase 3)
Sarcoidosis (Phase 2)
Sarcoma, Myeloid (Phase 2)
Schizophrenia (Phase 2)
Schizophrenia, Paranoid (Phase 2)
Schizophrenia, Treatment-Resistant (Phase 1)
Scleritis (Phase 1/Phase 2)
Scleroderma, Diffuse (Phase 2)
Scleroderma, Systemic (Phase 2/Phase 3)
Sclerosis (Phase 2/Phase 3)
Sezary Syndrome (Phase 2)
Sialadenitis (Phase 1/Phase 2)
Sjogren's Syndrome (Phase 2/Phase 3)
Spondylitis, Ankylosing (Phase 2/Phase 3)
Squamous Cell Carcinoma of Head and Neck (Phase 1)
Squamous Intraepithelial Lesions (Phase 3)
Stem Cell Transplantation (Phase 2)
Stiff-Person Syndrome (Phase 2)
Stomach Neoplasms (Phase 2)
Sweat (Phase 2)
Systemic Vasculitis (Phase 2)
Takayasu Arteritis (Phase 2)
Testicular Neoplasms (Phase 2)
Thalassemia (Phase 2)
Thalidomide (Phase 3)
Therapeutics (Phase 1/Phase 2)
Thrombocytopenia (Phase 4)
Thyroid Gland (Phase 1/Phase 2)
Translocation, Genetic (Phase 2)
Transplantation (Phase 2)
Tumor Suppressor Protein p53 (Phase 2)
Urticaria (Phase 1/Phase 2)
Vascular Grafting (Phase 2)
Vasculitis (Phase 2/Phase 3)
Viruses (Phase 2)
Waldenstrom Macroglobulinemia (Phase 4)
Weight Loss (Phase 2)
Wet Macular Degeneration (Phase 3)
Xerostomia (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
